Dr Reddys Laboratories (RDY) Divestments (2010 - 2017)
Dr Reddys Laboratories (RDY) posted quarterly Divestments of -$10.2 billion for Q4 2017, down 596.07% year-on-year from $2.1 billion in Q4 2016, and down 95.52% on a QoQ basis from -$5.2 billion in Q3 2017.
Dr Reddys Laboratories (RDY) Divestments (2010 - 2017) Analysis & Trends
Dr Reddys Laboratories (RDY) has reported Divestments for 7 consecutive years, with -$10.2 billion the latest figure, recorded in Q4 2017.
- Quarterly Divestments fell 596.07% year-over-year to -$10.2 billion in Q4 2017, while the trailing twelve-month figure through Dec 2017 was -$39.4 billion (down 13.94% YoY) and the FY2013 annual result came in at -$13.9 billion, up 25.29% from the prior year.
- Divestments retreated to -$10.2 billion in Q4 2017 per RDY's latest filing, from -$5.2 billion in the prior quarter.
- Over the last five years, Divestments for RDY reached as high as $3.2 billion in Q4 2013 and fell as low as -$26.0 billion in Q3 2016.
- A 4-year average of -$5.4 billion and a median of -$5.0 billion in 2013 frame the typical range for Divestments.
- Annual changes were most pronounced in 2013 — Divestments jumped 235.27% — and 2016, when it tumbled 1513.2%.
- Year by year, Divestments stood at $3.2 billion in 2013, then tumbled by 384.24% to -$9.0 billion in 2015, then soared by 122.86% to $2.1 billion in 2016, then plunged by 596.07% to -$10.2 billion in 2017.
- According to Business Quant data, Divestments over the past three periods registered -$10.2 billion, -$5.2 billion, and $2.1 billion for Q4 2017, Q3 2017, and Q4 2016 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 42.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.28 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -10.22 Bn |
| Sep 30, 2017 | -5.23 Bn |
| Dec 31, 2016 | 2.06 Bn |
| Sep 30, 2016 | -26.04 Bn |
| Dec 31, 2015 | -9.02 Bn |
| Sep 30, 2015 | -1.61 Bn |
| Jun 30, 2015 | -4.64 Bn |
| Dec 31, 2013 | 3.17 Bn |
| Sep 30, 2013 | 1.87 Bn |
| Jun 30, 2013 | -5.00 Bn |
| Mar 31, 2013 | -5.08 Bn |
| Dec 31, 2012 | -2.35 Bn |
| Sep 30, 2012 | -2.42 Bn |
| Jun 30, 2012 | -4.10 Bn |
| Mar 31, 2012 | -10.28 Bn |
| Dec 31, 2011 | -1.38 Bn |
| Sep 30, 2011 | -3.55 Bn |
| Mar 31, 2011 | -2.90 Bn |
| Mar 31, 2010 | -3.64 Bn |